IL17A and neoplasm: Moreover, IL-1-induced inflammation can activate RSPO3 expression in mesenchymal cells and, together with IL-17 activity and matrix metalloproteinases (e.g., MMP2 and MMP3) produced by iCAFs, stimulates angiogenesis and promotes tumor progression [74,75,76].